People · Operator

Amy F. Perry

Named in public records as an officer, director or promoter · active 2017–2017 · Healthtech

1
Companies
1
Filings
$49.6M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Palo Alto Health Sciences, Inc.HealthtechSeries B$49.6M$166.2M2017
Operator network

Amy F. Perry at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Stephen Bruso · 9 companies · 1 sharedStephen BrusoNed Scheetz · 8 companies · 1 sharedNed ScheetzJonathan MacQuitty · 7 companies · 1 sharedJonathan MacQuittyRussell Siegelman · 5 companies · 1 sharedRussell SiegelmanEdwin F. Scheetz · 3 companies · 1 sharedEdwin F. ScheetzDebra Reisenthel · 2 companies · 1 sharedDebra ReisenthelSIMON THOMAS · 2 companies · 1 sharedSIMON THOMASSteve Schwartz · 2 companies · 1 sharedSteve SchwartzDean F. Sawyer · 1 companies · 1 sharedDean F. SawyerEDWIN SHEETZ · 1 companies · 1 sharedEDWIN SHEETZElizabeth Siegelman · 1 companies · 1 sharedElizabeth Siegelm…Jonathan F. MacQuitty · 1 companies · 1 sharedJonathan F. MacQu…JOSEPH PEREKUPKA · 1 companies · 1 sharedJOSEPH PEREKUPKASimon F. Thomas · 1 companies · 1 sharedSimon F. ThomasPalo Alto Health Sciences, Inc. · $49.6M raisedPalo Alto Health Scie…Amy F. PerryAP
Amy F. Perry Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Amy F. Perry on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Stephen Bruso19
Ned Scheetz18
Jonathan MacQuitty17
Russell Siegelman15
Edwin F. Scheetz13
Steve Schwartz12
Debra Reisenthel12
SIMON THOMAS12
Jonathan F. MacQuitty11
EDWIN SHEETZ11
JOSEPH PEREKUPKA11
Dean F. Sawyer11
Simon F. Thomas11
Elizabeth Siegelman11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.